A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy
暂无分享,去创建一个
Manoj Kumar | J. Sharifi‐Rad | D. Calina | A. Docea | M. Martorell | F. Sharopov | M. Mahomoodally | Manoj Kumar | D. Dias | N. Cruz-Martins | C. Quispe | D. Lobine | Jesús Herrera-Bravo | T. Tumer | A. Moreira | Begum Kurt | Chintha Lankatillake
[1] B. Salehi,et al. Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits , 2021, Frontiers in Pharmacology.
[2] B. Salehi,et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.
[3] C. Tonelli,et al. The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action , 2020, Frontiers in Pharmacology.
[4] D. Calina,et al. The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies , 2020, Journal of clinical medicine.
[5] M. Sharifi-Rad,et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases , 2020, Frontiers in Physiology.
[6] R. Tulsawani,et al. Loss of Protection by Antiepileptic Drugs in Lipopolysaccharide-primed Pilocarpine-induced Status Epilepticus is Mediated via Inflammatory Signalling , 2020, Neuroscience.
[7] M. Sharifi-Rad,et al. Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds , 2020, International journal of environmental research and public health.
[8] B. Salehi,et al. Rosmarinus plants: Key farm concepts towards food applications , 2020, Phytotherapy research : PTR.
[9] B. Salehi,et al. Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases , 2020, Journal of clinical medicine.
[10] D. Calina,et al. Cannabinoids in the Pathophysiology of Skin Inflammation , 2020, Molecules.
[11] B. Salehi,et al. Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited , 2020, Biomolecules.
[12] PRELIMINARY SCREENING OF A CLASSICAL UNANI FORMULATION MAJOON NAJAH FOR ANTICONVULSANT ACTIVITY , 2019, International Journal of Pharmaceutical Research.
[13] J. Sharifi‐Rad,et al. A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse , 2019, Journal of clinical medicine.
[14] P. Iwanowski,et al. Advances in the Potential Biomarkers of Epilepsy , 2019, Front. Neurol..
[15] R. Macdonald,et al. A structural look at GABAA receptor mutations linked to epilepsy syndromes , 2019, Brain Research.
[16] Tyler Bahr,et al. The Effects of Various Essential Oils on Epilepsy and Acute Seizure: A Systematic Review , 2019, Evidence-based complementary and alternative medicine : eCAM.
[17] Dong Woon Kim,et al. Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy , 2019, Advances in nutrition.
[18] Z. Selamoğlu,et al. Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential , 2019, Molecules.
[19] B. Salehi,et al. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties , 2019, Biomolecules.
[20] L. Borgelt,et al. Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes , 2019, The Annals of pharmacotherapy.
[21] Jasenko Zivanov,et al. GABAA receptor signalling mechanisms revealed by structural pharmacology , 2019, Nature.
[22] O. Devinsky,et al. Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial , 2018, Epilepsia.
[23] A. Satish,et al. EVALUATION OF THE ANTICONVULSANT ACTIVITY OF ETHANOL EXTRACT OF PSIDIUM GUAJAVA (GUAVA LEAVES) IN ALBINO MICE , 2019 .
[24] B. Salehi,et al. Epibatidine: A Promising Natural Alkaloid in Health , 2018, Biomolecules.
[25] A. Zaitsev,et al. Seizure-Induced Potentiation of AMPA Receptor-Mediated Synaptic Transmission in the Entorhinal Cortex , 2018, Front. Cell. Neurosci..
[26] Seda Savranoglu Kulabas,et al. Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. , 2018, Journal of ethnopharmacology.
[27] Anup D. Patel,et al. Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results , 2018, Epilepsia.
[28] A. Mukherjee,et al. Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress , 2018 .
[29] B. Salehi,et al. Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications. , 2018, Microbiological research.
[30] Anup D. Patel,et al. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome , 2018, The New England journal of medicine.
[31] I. Scheffer,et al. Epilepsy , 2018, Nature Reviews Disease Primers.
[32] Eric Marsh,et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial , 2018, The Lancet.
[33] A. Asadi-Pooya. Lennox-Gastaut syndrome: a comprehensive review , 2018, Neurological Sciences.
[34] R. Khan,et al. Anticonvulsant Effects of Trigonella foenum-Graecum L. in Strychnine Induced Epilepsy Model , 2017 .
[35] D. Friedman,et al. Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open‐label clinical study with cannabidiol , 2017, Epilepsia.
[36] Dinesh Y. Gawande,et al. Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn. , 2017, Journal of ethnopharmacology.
[37] Tongtong Ge,et al. The effects of herbal medicine on epilepsy , 2017, Oncotarget.
[38] E. Wirrell,et al. Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel. , 2017, Pediatric neurology.
[39] K. Lundstrom,et al. Interaction of Plant Extracts with Central Nervous System Receptors , 2017, Medicines.
[40] A. Bhandari,et al. Antiepileptic activity of Murraya Koenigii Leaf Extracts , 2016 .
[41] S. Nabavi,et al. Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases , 2016, Pharmacological reports : PR.
[42] Peng Li,et al. Protective Effects of Otophylloside N on Pentylenetetrazol-Induced Neuronal Injury In vitro and In vivo , 2016, Front. Pharmacol..
[43] P. Mazumder,et al. Antiepileptic Activity of Methanol Extract of Butea monosperma (Lam.)Kuntze and its Isoalted Bioactive Compound in Experimentally InducedConvulsion in Swiss Albino Mice , 2016 .
[44] M. Carles,et al. A pharmacological basis of herbal medicines for epilepsy , 2015, Epilepsy & Behavior.
[45] C. Bladen,et al. Anticonvulsant mechanisms of piperine, a piperidine alkaloid , 2015, Channels.
[46] A. Becker,et al. Methanol extract of Ficus platyphylla ameliorates seizure severity, cognitive deficit and neuronal cell loss in pentylenetetrazole-kindled mice. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[47] R. M. de Freitas,et al. The Role of Flavonoids on Oxidative Stress in Epilepsy , 2015, Oxidative medicine and cellular longevity.
[48] Ji-min Cao,et al. Tanshinone II-A sodium sulfonate (DS-201) enhances human BKCa channel activity by selectively targeting the pore-forming α subunit , 2014, Acta Pharmacologica Sinica.
[49] R. Ramani,et al. Antiepileptic activity of leaves of Leucas aspera. , 2014 .
[50] Surajit Banerjee,et al. X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors , 2014, Nature.
[51] A. Becker,et al. The anxiolytic effects of a Valerian extract is based on Valerenic acid , 2014, BMC Complementary and Alternative Medicine.
[52] Benjamin J. Whalley,et al. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders , 2014, Epilepsia.
[53] T. Snutch,et al. Low threshold T‐type calcium channels as targets for novel epilepsy treatments , 2014, British journal of clinical pharmacology.
[54] J. H. Cross,et al. ILAE Official Report: A practical clinical definition of epilepsy , 2014, Epilepsia.
[55] R. Verpoorte,et al. What is in a name? The need for accurate scientific nomenclature for plants. , 2014, Journal of ethnopharmacology.
[56] T. Heinbockel,et al. Identification of both GABAA receptors and voltage-activated Na+ channels as molecular targets of anticonvulsant α-asarone , 2014, Front. Pharmacol..
[57] N. Mirazi,et al. Acute administration of ginger (Zingiber officinale rhizomes) extract on timed intravenous pentylenetetrazol infusion seizure model in mice , 2014, Epilepsy Research.
[58] O. Kudlacek,et al. Mechanism of hERG Channel Block by the Psychoactive Indole Alkaloid Ibogaine , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[59] P. Forgó,et al. Diterpene Alkaloids from the Roots of Aconitum moldavicum and Assessment of Nav 1.2 Sodium Channel Activity of Aconitum Alkaloids , 2014, Planta Medica.
[60] Peng Li,et al. Medicinal compounds with antiepileptic/anticonvulsant activities , 2014, Epilepsia.
[61] Walter Sandtner,et al. Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile☆ , 2013, Toxicology and applied pharmacology.
[62] W. Luyten,et al. Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models. , 2013, ACS chemical neuroscience.
[63] R. Mohanraj,et al. VGKC complex antibodies in epilepsy: Diagnostic yield and therapeutic implications , 2013, Seizure.
[64] P. Forgó,et al. Identification of diterpene alkaloids from Aconitum napellus subsp. firmum and GIRK channel activities of some Aconitum alkaloids. , 2013, Fitoterapia.
[65] Yan-wen Shu,et al. Curcumin Serves as a Human Kv1.3 Blocker to Inhibit Effector Memory T Lymphocyte Activities , 2013, Phytotherapy research : PTR.
[66] C. Schwarzer,et al. GABAA receptor modulation by piperine and a non-TRPV1 activating derivative☆ , 2013, Biochemical pharmacology.
[67] A. Kimbaris,et al. Increased Seizure Latency and Decreased Severity of Pentylenetetrazol-Induced Seizures in Mice after Essential Oil Administration , 2013, Epilepsy research and treatment.
[68] Cheng-Wei Lu,et al. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals. , 2013, Journal of ethnopharmacology.
[69] F. Scorza,et al. Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms , 2013, Pharmacology Biochemistry and Behavior.
[70] A. Mandegary,et al. Anticonvulsant Activity and Toxicity of Essential Oil and Methanolic Extract of Zhumeria majdae Rech, a Unique Iranian Plant in Mice , 2012, Neurochemical Research.
[71] Marjan Nassiri-Asl,et al. Neuroprotective Effects of Vitexin, a Flavonoid, on Pentylenetetrazole‐Induced Seizure in Rats , 2012, Chemical biology & drug design.
[72] A. Gorji,et al. Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain , 2012, BMC Complementary and Alternative Medicine.
[73] Mahfoozur Rahman,et al. Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats. , 2012, Journal of ethnopharmacology.
[74] Shao-qun Luan,et al. Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats , 2012, Neuroscience Letters.
[75] H. Fachim,et al. Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu Mart. ex Benth: Evaluating its anticonvulsant and anxiolytic potential , 2012, Epilepsy & Behavior.
[76] A. Asadi-Pooya,et al. Old Remedies for Epilepsy: Avicenna’s Medicine , 2012, Iranian Red Crescent medical journal.
[77] Damanpreet Singh,et al. Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression. , 2012, Journal of ethnopharmacology.
[78] P. Sharma,et al. Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb . , 2012 .
[79] G. Gupta,et al. Anticonvulsant and depressant-like activity of ursolic acid stearoyl glucoside isolated from Lantana camara L. (verbanaceae) , 2012 .
[80] Sheng-Nan Wu,et al. Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability , 2012, Psychopharmacology.
[81] S. Schachter,et al. The NMDA receptor complex as a therapeutic target in epilepsy: a review , 2011, Epilepsy & Behavior.
[82] A. Rakotonirina,et al. Antiepileptic Medicinal Plants used in Traditional Medicine to Treat Epilepsy , 2011 .
[83] D. Kang,et al. Baicalein and wogonin are activators of rat TREK‐2 two‐pore domain K+ channel , 2011, Acta physiologica.
[84] J. Hanrahan,et al. Flavonoid modulation of GABAA receptors , 2011, British journal of pharmacology.
[85] S. Schachter. Botanicals and herbs: A traditional approach to treating epilepsy , 2009, Neurotherapeutics.
[86] A. Jalsrai,et al. Evaluation of the effects of Astragalus mongholicus Bunge saponin extract on central nervous system functions. , 2010, Journal of ethnopharmacology.
[87] D. Rossi,et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[88] R. Almeida,et al. Carvacrol, (-)-Borneol and citral reduce convulsant activity in rodents. , 2010 .
[89] P. Bhutada,et al. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice , 2010, Epilepsy & Behavior.
[90] Marjan Nassiri-Asl,et al. The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats , 2010, Epilepsy & Behavior.
[91] Arijit Basu,et al. Anticonvulsant activity of Benkara malabarica (Linn.) root extract: In vitro and in vivo investigation. , 2010, Journal of ethnopharmacology.
[92] Benjamin J. Whalley,et al. Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo , 2010, Journal of Pharmacology and Experimental Therapeutics.
[93] Zhuo Yang,et al. Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage‐dependent sodium channels in hippocampal CA1 pyramidal neurons , 2010, Phytotherapy research : PTR.
[94] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[95] Barbara Bloom,et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.
[96] A. Hartman,et al. The ketogenic diet: Uses in epilepsy and other neurologic illnesses , 2008, Current treatment options in neurology.
[97] S. Schachter. Complementary and alternative medical therapies , 2008, Current opinion in neurology.
[98] Byung-Hwan Lee,et al. Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes. , 2006, Molecules and cells.
[99] M. Moshi,et al. Plants used to treat epilepsy by Tanzanian traditional healers. , 2005, Journal of ethnopharmacology.
[100] G. Sperk,et al. Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus , 2004, The Journal of Neuroscience.
[101] M. Leal,et al. Long-Lasting Ibogaine Protection against NMDA-Induced Convulsions in Mice , 2000, Neurochemical Research.
[102] P. Cooper,et al. Ketogenic diet for epilepsy. , 2003, The Cochrane database of systematic reviews.
[103] Xinmin Li,et al. Clinical observation on 930 child epilepsy cases treated with anti-epilepsy capsules. , 2003, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.
[104] H. Chiang,et al. Stimulation of the BKCa channel in cultured smooth muscle cells of human trachea by magnolol , 2002, Thorax.
[105] A. Gorji,et al. History of epilepsy in Medieval Iranian medicine , 2001, Neuroscience & Biobehavioral Reviews.
[106] J. Elferink. Epilepsy and Its Treatment in the Ancient Cultures of America , 1999, Epilepsia.
[107] W. Matuja,et al. Knowledge, attitude and practice (KAP) towards epilepsy in secondary school students in Tanzania. , 1994, The Central African journal of medicine.
[108] B. Manyam. Epilepsy in Ancient India , 1992, Epilepsia.
[109] C. Lai,et al. History of Epilepsy in Chinese Traditional Medicine , 1991, Epilepsia.
[110] A. Sacaan,et al. Anticonvulsant Effects of Some Arab Medicinal Plants , 1987 .
[111] Valverde Jl. The aztec herbal of 1552. Martín de la Cruz' "Libellus de medicinalibus indorum herbis"; context of the sources on nahualt materia medica. , 1984 .
[112] J. Valverde. The aztec herbal of 1552. Martín de la Cruz' "Libellus de medicinalibus indorum herbis"; context of the sources on nahualt materia medica. , 1984, Veroffentlichungen der Internationalen Gesellschaft fur Geschichte der Pharmazie e. V.
[113] K. Mattock,et al. Chinese medicine. , 1976, The Australasian nurses journal.
[114] M. G. Peterman,et al. Ketogenic Diet for Epilepsy , 2008 .